论文部分内容阅读
目的观察痰热清雾化吸入对治疗社区获得性肺炎的临床疗效。方法将56例社区获得性肺炎的患者随机分为试验组和对照组各28例,2组均给常规的抗感染和化痰治疗,在此基础上试验组给予痰热清注射液雾化吸入治疗;对照组给予氨溴索注射液雾化吸入治疗,2组疗程均为12d。观察2组治疗前后白细胞总数及C反应蛋白水平变化。结果 2组治疗前白细胞总数、C反应蛋白水平比较差异均无统计学意义(P>0.05)。治疗12d后2组的白细胞总数、C反应蛋白较治疗前均有明显改善,且试验组优于对照组,差异均有统计学意义(P<0.05)。结论痰热清注射液雾化吸入治疗社区获得性肺炎有较好的疗效。
Objective To observe the clinical effect of Tanreqing spray inhalation on community-acquired pneumonia. Methods 56 cases of community-acquired pneumonia were randomly divided into experimental group and control group of 28 cases, two groups were given conventional anti-infective and phlegm treatment, on this basis, the experimental group given Tanreqing injection aerosol inhalation The control group was given ambroxol injection for inhalation therapy, and the two courses of treatment were 12 days. The total number of leukocytes and C-reactive protein in two groups before and after treatment were observed. Results There was no significant difference in the total number of leukocytes and C-reactive protein between the two groups before treatment (P> 0.05). After 12 days of treatment, the total number of leukocytes and C-reactive protein in both groups were significantly improved compared with that before treatment, and the experimental group was better than the control group (P <0.05). Conclusion Tanreqing injection nebulized inhalation treatment of community-acquired pneumonia has a good effect.